Importance of Multidrug Efflux Pumps in the Antimicrobial Resistance Property of Clinical Multidrug-Resistant Isolates of Neisseria gonorrhoeae

The contribution of drug efflux pumps in clinical isolates of Neisseria gonorrhoeae that express extensively drug-resistant or multidrug-resistant phenotypes has heretofore not been examined. Accordingly, we assessed the effect on antimicrobial resistance of loss of the three gonococcal efflux pumps...

Full description

Saved in:
Bibliographic Details
Published inAntimicrobial agents and chemotherapy Vol. 58; no. 6; pp. 3556 - 3559
Main Authors Golparian, Daniel, Shafer, William M., Ohnishi, Makoto, Unemo, Magnus
Format Journal Article
LanguageEnglish
Published Washington, DC American Society for Microbiology 01.06.2014
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The contribution of drug efflux pumps in clinical isolates of Neisseria gonorrhoeae that express extensively drug-resistant or multidrug-resistant phenotypes has heretofore not been examined. Accordingly, we assessed the effect on antimicrobial resistance of loss of the three gonococcal efflux pumps associated with a known capacity to export antimicrobials (MtrC-MtrD-MtrE, MacA-MacB, and NorM) in such clinical isolates. We report that the MIC of several antimicrobials, including seven previously and currently recommended for treatment was significantly impacted.
AbstractList The contribution of drug efflux pumps in clinical isolates of Neisseria gonorrhoeae that express extensively drug-resistant or multidrug-resistant phenotypes has heretofore not been examined. Accordingly, we assessed the effect on antimicrobial resistance of loss of the three gonococcal efflux pumps associated with a known capacity to export antimicrobials (MtrC-MtrD-MtrE, MacA-MacB, and NorM) in such clinical isolates. We report that the MIC of several antimicrobials, including seven previously and currently recommended for treatment was significantly impacted.
The contribution of drug efflux pumps in clinical isolates of Neisseria gonorrhoeae that express extensively drug-resistant or multidrug-resistant phenotypes has heretofore not been examined. Accordingly, we assessed the effect on antimicrobial resistance of loss of the three gonococcal efflux pumps associated with a known capacity to export antimicrobials (MtrC-MtrD-MtrE, MacA-MacB, and NorM) in such clinical isolates. We report that the MIC of several antimicrobials, including seven previously and currently recommended for treatment was significantly impacted.The contribution of drug efflux pumps in clinical isolates of Neisseria gonorrhoeae that express extensively drug-resistant or multidrug-resistant phenotypes has heretofore not been examined. Accordingly, we assessed the effect on antimicrobial resistance of loss of the three gonococcal efflux pumps associated with a known capacity to export antimicrobials (MtrC-MtrD-MtrE, MacA-MacB, and NorM) in such clinical isolates. We report that the MIC of several antimicrobials, including seven previously and currently recommended for treatment was significantly impacted.
The contribution of drug efflux pumps in clinical isolates of Neisseria gonorrhoeae that express extensively drug-resistant or multidrug-resistant phenotypes has heretofore not been examined. Accordingly, we assessed the effect on antimicrobial resistance of loss of the three gonococcal efflux pumps associated with a known capacity to export antimicrobials (MtrC-MtrD-MtrE, MacA-MacB, and NorM) in such clinical isolates. We report that the MIC of several antimicrobials, including seven previously and currently recommended for treatment was significantly impacted.
Author Golparian, Daniel
Ohnishi, Makoto
Unemo, Magnus
Shafer, William M.
Author_xml – sequence: 1
  givenname: Daniel
  surname: Golparian
  fullname: Golparian, Daniel
  organization: WHO Collaborating Centre for Gonorrhoea and other Sexually Transmitted Infections (STIs), National Reference Laboratory for Pathogenic Neisseria, Department of Laboratory Medicine, Microbiology, Örebro University Hospital, Örebro, Sweden
– sequence: 2
  givenname: William M.
  surname: Shafer
  fullname: Shafer, William M.
  organization: Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, USA, Laboratories of Bacterial Pathogenesis, Veterans Affairs Medical Center, Decatur, Georgia, USA
– sequence: 3
  givenname: Makoto
  surname: Ohnishi
  fullname: Ohnishi, Makoto
  organization: National Institute of Infectious Diseases, Tokyo, Japan
– sequence: 4
  givenname: Magnus
  surname: Unemo
  fullname: Unemo, Magnus
  organization: WHO Collaborating Centre for Gonorrhoea and other Sexually Transmitted Infections (STIs), National Reference Laboratory for Pathogenic Neisseria, Department of Laboratory Medicine, Microbiology, Örebro University Hospital, Örebro, Sweden
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28510068$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/24733458$$D View this record in MEDLINE/PubMed
https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-56403$$DView record from Swedish Publication Index
BookMark eNqNkk1v1DAQhi1URLcLN84oFySQSLFjJ3EuSNFSYKUCFQKulteZ7Lpy7GA7QH8Ffxkvu91SBBIHaw7zzOv5eE_QkXUWEHpI8CkhBX_etotTjDHlOWF30IzghudV2VRHaIZxVeWMY3aMTkK4TFRK4HvouGA1pazkM_RjOYzOR2kVZK7P3k4m6s5P6-ys7830PbuYhjFk2mZxA1lrox608m6lpck-QNBhV3nh3Qg-Xm0lFkZbrVL-oJVfkzFbBmdkhLAF34EOAbyW2dpZ5_3GgYT76G4vTYAH-zhHn16dfVy8yc_fv14u2vNclpzFXJGGs6LBBHdp1I6pguMKA29UU_CaU1r3gBtWNrSDFeEr6Mu-K2WlGFaKVYTO0bOdbvgG47QSo9eD9FfCSS1e6s-tcH6d3iTKimGa8Bc7PLEDdAps9NLcqrqdsXoj1u6rYLhKjdZJ4MlewLsvE4QoBh0UGCMtuCkIUrKmoiWh9D9QyjirSRpzjp7uUBmGQly6ydu0NEGw2FpDJGuIX9YQhCX20e8jHHq_9kICHu8BGdL9ep9Oq8MNx0uSDMRvVpeMEIKH_oD849_iD1zpKKN220Vp8_ein1Jp464
CODEN AACHAX
CitedBy_id crossref_primary_10_1093_nar_gkab213
crossref_primary_10_1136_sextrans_2019_054220
crossref_primary_10_1007_s00203_023_03663_0
crossref_primary_10_3389_fmicb_2015_01377
crossref_primary_10_1080_14728222_2017_1265105
crossref_primary_10_1080_1040841X_2019_1607248
crossref_primary_10_3389_fcimb_2022_924764
crossref_primary_10_1002_med_21591
crossref_primary_10_1038_s41467_020_17980_1
crossref_primary_10_1093_infdis_jiv517
crossref_primary_10_1007_s40203_023_00185_x
crossref_primary_10_3389_fmicb_2021_776909
crossref_primary_10_3390_antibiotics10020103
crossref_primary_10_1128_msphere_00362_22
crossref_primary_10_2217_fmb_2017_0258
crossref_primary_10_1016_j_ijid_2016_11_409
crossref_primary_10_1128_mBio_02277_19
crossref_primary_10_1097_IM9_0000000000000024
crossref_primary_10_1042_EBC20160064
crossref_primary_10_1021_acsinfecdis_4c00091
crossref_primary_10_1099_mic_0_001257
crossref_primary_10_1128_AAC_00863_20
crossref_primary_10_1093_infdis_jiw420
crossref_primary_10_1128_mBio_01576_19
crossref_primary_10_1186_s12879_016_1469_3
crossref_primary_10_3390_genes12091312
crossref_primary_10_1136_sextrans_2014_051730
crossref_primary_10_1093_jac_dky162
crossref_primary_10_1093_jac_dkw182
crossref_primary_10_1038_s41579_018_0048_6
crossref_primary_10_1080_14737159_2022_2015329
crossref_primary_10_1007_s00253_023_12646_6
crossref_primary_10_3389_fmicb_2018_02971
crossref_primary_10_1071_SH19016
crossref_primary_10_1074_mcp_RA118_001125
crossref_primary_10_1016_j_micpath_2023_106182
crossref_primary_10_3390_antibiotics10050538
crossref_primary_10_1146_annurev_micro_090816_093530
crossref_primary_10_1093_cid_ciu526
crossref_primary_10_1016_j_clinmicnews_2015_12_006
crossref_primary_10_3389_fmicb_2020_00169
crossref_primary_10_1128_CMR_00010_14
crossref_primary_10_1128_CMR_00117_14
crossref_primary_10_1371_journal_ppat_1012783
crossref_primary_10_1371_journal_ppat_1008602
crossref_primary_10_1093_femspd_ftx041
crossref_primary_10_1016_j_trsl_2020_02_002
crossref_primary_10_1093_gbe_evx210
crossref_primary_10_1128_mBio_02281_18
crossref_primary_10_1128_AAC_01542_21
crossref_primary_10_1128_AAC_00821_18
crossref_primary_10_1099_acmi_0_000689_v3
crossref_primary_10_1097_OLQ_0000000000000971
crossref_primary_10_1128_AAC_01497_17
crossref_primary_10_1128_AAC_02798_15
crossref_primary_10_3390_vaccines10070983
crossref_primary_10_1093_femsre_fuac032
crossref_primary_10_1371_journal_ppat_1012578
crossref_primary_10_1021_acs_chemrev_1c00055
crossref_primary_10_1002_phar_1627
crossref_primary_10_1186_s40659_024_00543_9
crossref_primary_10_1016_S1473_3099_17_30310_9
crossref_primary_10_1007_s00430_019_00651_4
crossref_primary_10_1016_j_compbiolchem_2022_107682
crossref_primary_10_1016_j_meegid_2023_105449
crossref_primary_10_1093_jac_dky412
crossref_primary_10_3389_fmicb_2021_683901
crossref_primary_10_1093_jac_dkab024
crossref_primary_10_1016_j_drup_2016_06_007
crossref_primary_10_1038_s41598_017_16995_x
crossref_primary_10_1128_AAC_00786_15
crossref_primary_10_1016_j_biomaterials_2015_02_063
Cites_doi 10.1128/AAC.46.9.2811-2820.2002
10.1093/jac/dks162
10.1016/j.molmed.2005.06.006
10.1093/jac/dkt034
10.1128/AAC.05760-11
10.1177/0956462412472837
10.1099/13500872-141-3-611
10.1128/jb.177.14.4162-4165.1995
10.1073/pnas.95.4.1829
10.1128/AAC.02093-13
10.1111/j.1365-2958.2008.06424.x
10.1128/AAC.00325-11
10.1128/JB.185.3.1101-1106.2003
10.2217/fmb.12.117
10.1093/jac/dki333
10.1016/j.bcp.2005.12.008
10.2807/ese.16.06.19792-en
10.1021/bi101167x
10.1086/522964
10.1093/jac/dkt017
10.1093/jac/dkp098
10.1128/IAI.71.10.5576-5582.2003
10.1128/AAC.00304-09
10.1128/mBio.00187-11
10.1128/JB.01165-08
10.1099/00221287-144-3-621
10.2807/ese.15.47.19721-en
10.1128/AAC.43.10.2468
10.1128/JB.184.20.5619-5624.2002
10.1586/eri.09.63
10.1093/jac/dkl493
10.1056/NEJMp1112456
10.1136/sti.2010.042648
10.1001/jama.2012.176575
10.1007/s004380050196
10.1128/JB.188.7.2300-2308.2006
ContentType Journal Article
Copyright 2015 INIST-CNRS
Copyright © 2014, American Society for Microbiology. All Rights Reserved.
Copyright © 2014, American Society for Microbiology. All Rights Reserved. 2014 American Society for Microbiology
Copyright_xml – notice: 2015 INIST-CNRS
– notice: Copyright © 2014, American Society for Microbiology. All Rights Reserved.
– notice: Copyright © 2014, American Society for Microbiology. All Rights Reserved. 2014 American Society for Microbiology
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7QL
7T7
8FD
C1K
FR3
P64
7X8
5PM
ADTPV
AOWAS
D91
DOI 10.1128/AAC.00038-14
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Bacteriology Abstracts (Microbiology B)
Industrial and Applied Microbiology Abstracts (Microbiology A)
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
SwePub
SwePub Articles
SWEPUB Örebro universitet
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Engineering Research Database
Technology Research Database
Industrial and Applied Microbiology Abstracts (Microbiology A)
Bacteriology Abstracts (Microbiology B)
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList Engineering Research Database
MEDLINE - Academic

CrossRef


MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
Pharmacy, Therapeutics, & Pharmacology
EISSN 1098-6596
EndPage 3559
ExternalDocumentID oai_DiVA_org_oru_56403
PMC4068427
00038-14
24733458
28510068
10_1128_AAC_00038_14
Genre Research Support, U.S. Gov't, Non-P.H.S
Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIAID NIH HHS
  grantid: R37 AI021150
– fundername: NIAID NIH HHS
  grantid: U19AI031496
– fundername: NIAID NIH HHS
  grantid: U19 AI031496
GroupedDBID ---
.55
.GJ
0R~
23M
2WC
39C
3O-
4.4
53G
5GY
5RE
5VS
6J9
AAGFI
AAYXX
ACGFO
ADBBV
AENEX
AGNAY
AGVNZ
AI.
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BTFSW
C1A
CITATION
CS3
DIK
E3Z
EBS
EJD
F5P
FRP
GX1
H13
HH5
HYE
HZ~
H~9
J5H
K-O
KQ8
L7B
LSO
MVM
NEJ
O9-
OK1
P2P
RHI
RNS
RPM
RSF
TR2
UHB
VH1
W2D
W8F
WH7
WHG
WOQ
X7M
X7N
XOL
Y6R
ZGI
ZXP
~A~
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
RHF
-
0R
55
AAPBV
ABFLS
ADACO
BXI
HZ
ZA5
7QL
7T7
8FD
C1K
FR3
P64
7X8
5PM
ADTPV
AOWAS
D91
ID FETCH-LOGICAL-a584t-c198429010d596d4c28060e89c92878337fe094593deb18bef5fd5a6c40cc4613
ISSN 0066-4804
1098-6596
IngestDate Thu Aug 21 06:55:29 EDT 2025
Thu Aug 21 18:01:50 EDT 2025
Fri Jul 11 08:46:11 EDT 2025
Fri Jul 11 04:36:25 EDT 2025
Tue Dec 28 13:58:58 EST 2021
Thu Jan 02 22:17:14 EST 2025
Wed Apr 02 07:20:27 EDT 2025
Tue Jul 01 04:32:22 EDT 2025
Thu Apr 24 22:50:02 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords Human
Drug susceptibility test
Neisseriaceae
Antimicrobial agent
Infection
Sexually transmitted disease
Gonococcal infection
Neisseria gonorrhoeae
Membrane pump
Membrane transport
Multiple resistance
Bacteriosis
Bacteria
Micrococcales
Clinical isolate
Language English
License CC BY 4.0
Copyright © 2014, American Society for Microbiology. All Rights Reserved.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-a584t-c198429010d596d4c28060e89c92878337fe094593deb18bef5fd5a6c40cc4613
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
OpenAccessLink https://aac.asm.org/content/aac/58/6/3556.full.pdf
PMID 24733458
PQID 1534847178
PQPubID 23462
PageCount 4
ParticipantIDs swepub_primary_oai_DiVA_org_oru_56403
pubmedcentral_primary_oai_pubmedcentral_nih_gov_4068427
proquest_miscellaneous_1549635133
proquest_miscellaneous_1534847178
asm2_journals_10_1128_AAC_00038_14
pubmed_primary_24733458
pascalfrancis_primary_28510068
crossref_primary_10_1128_AAC_00038_14
crossref_citationtrail_10_1128_AAC_00038_14
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2014-06-01
PublicationDateYYYYMMDD 2014-06-01
PublicationDate_xml – month: 06
  year: 2014
  text: 2014-06-01
  day: 01
PublicationDecade 2010
PublicationPlace Washington, DC
PublicationPlace_xml – name: Washington, DC
– name: United States
– name: 1752 N St., N.W., Washington, DC
PublicationTitle Antimicrobial agents and chemotherapy
PublicationTitleAbbrev Antimicrob Agents Chemother
PublicationTitleAlternate Antimicrob Agents Chemother
PublicationYear 2014
Publisher American Society for Microbiology
Publisher_xml – name: American Society for Microbiology
References e_1_3_2_26_2
e_1_3_2_27_2
e_1_3_2_28_2
e_1_3_2_29_2
e_1_3_2_40_2
e_1_3_2_20_2
e_1_3_2_21_2
e_1_3_2_22_2
e_1_3_2_23_2
e_1_3_2_24_2
e_1_3_2_25_2
Centers for Disease Control and Prevention (CDC) (e_1_3_2_30_2) 2012; 61
e_1_3_2_9_2
e_1_3_2_15_2
e_1_3_2_38_2
e_1_3_2_8_2
e_1_3_2_16_2
e_1_3_2_37_2
e_1_3_2_7_2
e_1_3_2_17_2
e_1_3_2_6_2
e_1_3_2_18_2
e_1_3_2_39_2
e_1_3_2_19_2
e_1_3_2_10_2
e_1_3_2_31_2
e_1_3_2_5_2
e_1_3_2_11_2
e_1_3_2_34_2
e_1_3_2_4_2
e_1_3_2_12_2
e_1_3_2_33_2
e_1_3_2_3_2
e_1_3_2_13_2
e_1_3_2_36_2
e_1_3_2_14_2
e_1_3_2_35_2
Shafer WM (e_1_3_2_32_2) 2010
World Health Organization (e_1_3_2_2_2) 2012
18978065 - J Bacteriol. 2009 Jan;191(1):287-97
7711899 - Microbiology. 1995 Mar;141 ( Pt 3):611-22
16547016 - J Bacteriol. 2006 Apr;188(7):2300-8
21329645 - Euro Surveill. 2011;16(6). pii: 19792
20656721 - Sex Transm Infect. 2010 Nov;86(6):415-21
16427026 - Biochem Pharmacol. 2006 Mar 30;71(7):910-8
23231489 - Future Microbiol. 2012 Dec;7(12):1401-22
23390207 - J Antimicrob Chemother. 2013 Jun;68(6):1445-7
20704258 - Biochemistry. 2010 Sep 21;49(37):8062-70
19318360 - J Antimicrob Chemother. 2009 Jun;63(6):1142-51
12270819 - J Bacteriol. 2002 Oct;184(20):5619-24
22155830 - Antimicrob Agents Chemother. 2012 Mar;56(3):1273-80
23416957 - J Antimicrob Chemother. 2013 Jun;68(6):1267-70
22566592 - J Antimicrob Chemother. 2012 Aug;67(8):1858-60
9465102 - Proc Natl Acad Sci U S A. 1998 Feb 17;95(4):1829-33
10508026 - Antimicrob Agents Chemother. 1999 Oct;43(10):2468-72
21576437 - Antimicrob Agents Chemother. 2011 Jul;55(7):3538-45
14500476 - Infect Immun. 2003 Oct;71(10):5576-82
22316442 - N Engl J Med. 2012 Feb 9;366(6):485-7
16162665 - J Antimicrob Chemother. 2005 Nov;56(5):856-60
18761689 - Mol Microbiol. 2008 Oct;70(2):462-78
21933917 - MBio. 2011;2(5). pii: e00187-11. doi: 10.1128/mBio.00187-11
7608095 - J Bacteriol. 1995 Jul;177(14):4162-5
9534233 - Microbiology. 1998 Mar;144 ( Pt 3):621-7
24400344 - Int J STD AIDS. 2013 Feb;24(2):85-92
15996519 - Trends Mol Med. 2005 Aug;11(8):382-9
12533487 - J Bacteriol. 2003 Feb;185(3):1101-6
12183233 - Antimicrob Agents Chemother. 2002 Sep;46(9):2811-20
8709956 - Mol Gen Genet. 1996 Jul 19;251(5):509-17
18190261 - J Infect Dis. 2007 Dec 15;196(12):1804-12
19735224 - Expert Rev Anti Infect Ther. 2009 Sep;7(7):821-34
19528266 - Antimicrob Agents Chemother. 2009 Sep;53(9):3744-51
22874837 - MMWR Morb Mortal Wkly Rep. 2012 Aug 10;61(31):590-4
23299608 - JAMA. 2013 Jan 9;309(2):163-70
24189248 - Antimicrob Agents Chemother. 2014;58(1):624-5
17229832 - J Antimicrob Chemother. 2007 Jun;59(6):1223-9
21144442 - Euro Surveill. 2010 Nov 25;15(47). pii: 19721
References_xml – ident: e_1_3_2_19_2
  doi: 10.1128/AAC.46.9.2811-2820.2002
– ident: e_1_3_2_14_2
  doi: 10.1093/jac/dks162
– ident: e_1_3_2_40_2
  doi: 10.1016/j.molmed.2005.06.006
– ident: e_1_3_2_9_2
  doi: 10.1093/jac/dkt034
– ident: e_1_3_2_8_2
  doi: 10.1128/AAC.05760-11
– ident: e_1_3_2_31_2
  doi: 10.1177/0956462412472837
– ident: e_1_3_2_33_2
  doi: 10.1099/13500872-141-3-611
– ident: e_1_3_2_27_2
  doi: 10.1128/jb.177.14.4162-4165.1995
– ident: e_1_3_2_34_2
  doi: 10.1073/pnas.95.4.1829
– ident: e_1_3_2_26_2
  doi: 10.1128/AAC.02093-13
– ident: e_1_3_2_37_2
  doi: 10.1111/j.1365-2958.2008.06424.x
– ident: e_1_3_2_13_2
  doi: 10.1128/AAC.00325-11
– ident: e_1_3_2_24_2
  doi: 10.1128/JB.185.3.1101-1106.2003
– ident: e_1_3_2_4_2
  doi: 10.2217/fmb.12.117
– ident: e_1_3_2_23_2
  doi: 10.1093/jac/dki333
– ident: e_1_3_2_39_2
  doi: 10.1016/j.bcp.2005.12.008
– ident: e_1_3_2_11_2
  doi: 10.2807/ese.16.06.19792-en
– ident: e_1_3_2_15_2
  doi: 10.1021/bi101167x
– ident: e_1_3_2_36_2
  doi: 10.1086/522964
– ident: e_1_3_2_12_2
  doi: 10.1093/jac/dkt017
– ident: e_1_3_2_25_2
  doi: 10.1093/jac/dkp098
– ident: e_1_3_2_35_2
  doi: 10.1128/IAI.71.10.5576-5582.2003
– ident: e_1_3_2_16_2
  doi: 10.1128/AAC.00304-09
– volume-title: Global incidence and prevalence of selected curable sexually transmitted infections—2008
  year: 2012
  ident: e_1_3_2_2_2
– ident: e_1_3_2_18_2
  doi: 10.1128/mBio.00187-11
– ident: e_1_3_2_17_2
  doi: 10.1128/JB.01165-08
– ident: e_1_3_2_29_2
  doi: 10.1099/00221287-144-3-621
– ident: e_1_3_2_7_2
  doi: 10.2807/ese.15.47.19721-en
– ident: e_1_3_2_22_2
  doi: 10.1128/AAC.43.10.2468
– ident: e_1_3_2_21_2
  doi: 10.1128/JB.184.20.5619-5624.2002
– ident: e_1_3_2_3_2
  doi: 10.1586/eri.09.63
– ident: e_1_3_2_38_2
  doi: 10.1093/jac/dkl493
– ident: e_1_3_2_5_2
  doi: 10.1056/NEJMp1112456
– ident: e_1_3_2_6_2
  doi: 10.1136/sti.2010.042648
– ident: e_1_3_2_10_2
  doi: 10.1001/jama.2012.176575
– start-page: 245
  volume-title: Neisseria: molecular mechanisms of pathogenesis
  year: 2010
  ident: e_1_3_2_32_2
– volume: 61
  start-page: 590
  year: 2012
  ident: e_1_3_2_30_2
  article-title: Update to CDC's Sexually Transmitted Diseases Treatment Guidelines, 2010: oral cephalosporins no longer recommended for treatment of gonococcal infections
  publication-title: MMWR Morb. Mortal. Wkly. Rep.
– ident: e_1_3_2_28_2
  doi: 10.1007/s004380050196
– ident: e_1_3_2_20_2
  doi: 10.1128/JB.188.7.2300-2308.2006
– reference: 22566592 - J Antimicrob Chemother. 2012 Aug;67(8):1858-60
– reference: 23231489 - Future Microbiol. 2012 Dec;7(12):1401-22
– reference: 22155830 - Antimicrob Agents Chemother. 2012 Mar;56(3):1273-80
– reference: 14500476 - Infect Immun. 2003 Oct;71(10):5576-82
– reference: 15996519 - Trends Mol Med. 2005 Aug;11(8):382-9
– reference: 17229832 - J Antimicrob Chemother. 2007 Jun;59(6):1223-9
– reference: 7711899 - Microbiology. 1995 Mar;141 ( Pt 3):611-22
– reference: 16162665 - J Antimicrob Chemother. 2005 Nov;56(5):856-60
– reference: 19318360 - J Antimicrob Chemother. 2009 Jun;63(6):1142-51
– reference: 23390207 - J Antimicrob Chemother. 2013 Jun;68(6):1445-7
– reference: 21144442 - Euro Surveill. 2010 Nov 25;15(47). pii: 19721
– reference: 21329645 - Euro Surveill. 2011;16(6). pii: 19792
– reference: 20704258 - Biochemistry. 2010 Sep 21;49(37):8062-70
– reference: 20656721 - Sex Transm Infect. 2010 Nov;86(6):415-21
– reference: 12183233 - Antimicrob Agents Chemother. 2002 Sep;46(9):2811-20
– reference: 9534233 - Microbiology. 1998 Mar;144 ( Pt 3):621-7
– reference: 21933917 - MBio. 2011;2(5). pii: e00187-11. doi: 10.1128/mBio.00187-11
– reference: 23416957 - J Antimicrob Chemother. 2013 Jun;68(6):1267-70
– reference: 10508026 - Antimicrob Agents Chemother. 1999 Oct;43(10):2468-72
– reference: 16547016 - J Bacteriol. 2006 Apr;188(7):2300-8
– reference: 22316442 - N Engl J Med. 2012 Feb 9;366(6):485-7
– reference: 24400344 - Int J STD AIDS. 2013 Feb;24(2):85-92
– reference: 18761689 - Mol Microbiol. 2008 Oct;70(2):462-78
– reference: 7608095 - J Bacteriol. 1995 Jul;177(14):4162-5
– reference: 21576437 - Antimicrob Agents Chemother. 2011 Jul;55(7):3538-45
– reference: 23299608 - JAMA. 2013 Jan 9;309(2):163-70
– reference: 24189248 - Antimicrob Agents Chemother. 2014;58(1):624-5
– reference: 18190261 - J Infect Dis. 2007 Dec 15;196(12):1804-12
– reference: 16427026 - Biochem Pharmacol. 2006 Mar 30;71(7):910-8
– reference: 8709956 - Mol Gen Genet. 1996 Jul 19;251(5):509-17
– reference: 9465102 - Proc Natl Acad Sci U S A. 1998 Feb 17;95(4):1829-33
– reference: 19528266 - Antimicrob Agents Chemother. 2009 Sep;53(9):3744-51
– reference: 19735224 - Expert Rev Anti Infect Ther. 2009 Sep;7(7):821-34
– reference: 22874837 - MMWR Morb Mortal Wkly Rep. 2012 Aug 10;61(31):590-4
– reference: 18978065 - J Bacteriol. 2009 Jan;191(1):287-97
– reference: 12533487 - J Bacteriol. 2003 Feb;185(3):1101-6
– reference: 12270819 - J Bacteriol. 2002 Oct;184(20):5619-24
SSID ssj0006590
Score 2.4212804
Snippet The contribution of drug efflux pumps in clinical isolates of Neisseria gonorrhoeae that express extensively drug-resistant or multidrug-resistant phenotypes...
The contribution of drug efflux pumps in clinical isolates of Neisseria gonorrhoeae that express extensively drug-resistant or multidrug-resistant phenotypes...
SourceID swepub
pubmedcentral
proquest
asm2
pubmed
pascalfrancis
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 3556
SubjectTerms Anti-Bacterial Agents
Anti-Bacterial Agents - pharmacology
Antibiotics. Antiinfectious agents. Antiparasitic agents
Bacterial diseases
Bacterial diseases of the genital system
Bacterial Proteins - genetics
Bacterial Proteins - metabolism
Biological and medical sciences
Drug Resistance, Multiple, Bacterial - genetics
Epidemiology. Vaccinations
General aspects
Genes, MDR
Genes, MDR - physiology
Gonorrhea
Gonorrhea - microbiology
Human bacterial diseases
Humans
Infectious diseases
Mechanisms of Resistance
Medical sciences
Membrane Transport Proteins
Membrane Transport Proteins - genetics
Membrane Transport Proteins - metabolism
Microbial Sensitivity Tests
Mutation
Neisseria gonorrhoeae
Neisseria gonorrhoeae - drug effects
Neisseria gonorrhoeae - genetics
Pharmacology. Drug treatments
Title Importance of Multidrug Efflux Pumps in the Antimicrobial Resistance Property of Clinical Multidrug-Resistant Isolates of Neisseria gonorrhoeae
URI https://www.ncbi.nlm.nih.gov/pubmed/24733458
https://journals.asm.org/doi/10.1128/AAC.00038-14
https://www.proquest.com/docview/1534847178
https://www.proquest.com/docview/1549635133
https://pubmed.ncbi.nlm.nih.gov/PMC4068427
https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-56403
Volume 58
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF6VIhASQlBe4VEtCHpJHRx7_TpGBdSAgnJoUG_Wxl4nFokdJY5E-BP8Wu7M7K5fIkXQQ6zEWXttzTfrmfF8M4S8QV6AzQPbCEQ_Nti0Hxk-c2xDOIkV8NjkTPIrRl_c8wn7dOlcHhz8amQtbYtpL_qxl1dyHanCPpArsmT_Q7LVSWEHfAf5whYkDNt_kvFwKa1n1E3MZMHcwHi9nWG75MX2e3cMotqUiYyDrEiXqSy7JOvpb9BwxCPHGI5f68SMkidZncsoRxbdIdwMWqYyyCDke_yUd2d5lq_X81zwVlJRezo-k0Q6yaGbi6VmfdWJpPkCmyGqWKwivVeRnzlPFKp0ZKg76lWB4XmGETRFOfqWF3n5xySDOdTuWdaObPRZnYHVIBPgKtfIXx2ldX2q5rruugbzVSPjnlBLOVZKdR3VL7dc6x2_genmwg1ml9swAuBnsP8BYyFpYjA468mXqoZiwDawtlpKsFnMs22mp2sX9B6PzsCK8pnl3SA3LfBuZCRg-LkyIOCiFXNK31TJ17D8d82JsY61ngXsCb5ZWi3b6u6KbwAwierPss-B-jMPuFUtV1pYF_fJPe0a0YHC-QNyILIjcks1S90dkdsjnQZyRE7GquD67pRe1PzBzSk9oeO6FPvuIflZawjNE1qhmioNoVJDaJpRACRtQZbWGkJLDcFTlBpC92gILTUEB1YaQhsa8ohMPn64ODs3dAsSg4NlXhhRPwBBYQpTDEiKWYSJCKbwgyiwfM-3bS8RZsCcwI7B6PGnInGS2OFuxMwoYmAqPyaHWZ6Jp4TGHhceyND3goBxGxwDH3wfh3txP-KBZ3bIa5RhqNeXTSjdc8sPQeahlDm46R3SLSUcRrqIP_aSWVwx-m01eqWK11wx7rgFlmqwBf4Yksg65FWJnhAeP_hOkWci38JFOjZDA9f76xgGj3lsJNUhTxTi6hk0gjvEa2GxGoDl79v_ZOlclsHXSgQ3qVDbOuR9-nUQ5usZfLah4zLTfnbtGZ6TO_Xy9IIcFuuteAmuSDE9lor7GwlTOvE
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Importance+of+Multidrug+Efflux+Pumps+in+the+Antimicrobial+Resistance+Property+of+Clinical+Multidrug-Resistant+Isolates+of+Neisseria+gonorrhoeae&rft.jtitle=Antimicrobial+agents+and+chemotherapy&rft.au=Golparian%2C+Daniel&rft.au=Shafer%2C+William+M.&rft.au=Ohnishi%2C+Makoto&rft.au=Unemo%2C+Magnus&rft.date=2014-06-01&rft.pub=American+Society+for+Microbiology&rft.issn=0066-4804&rft.eissn=1098-6596&rft.volume=58&rft.issue=6&rft.spage=3556&rft.epage=3559&rft_id=info:doi/10.1128%2FAAC.00038-14&rft_id=info%3Apmid%2F24733458&rft.externalDocID=PMC4068427
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0066-4804&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0066-4804&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0066-4804&client=summon